Generics controversy issue widens

A dispute between the U.S. Justice Department and Federal Trade Commission over generic drugs is reportedly widening with implications for the drug firms.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news68728217.html">Generics controversy issue widens</a></p> <p>A dispute between the U.S. Justice Department and Federal Trade Commission over generic drugs is reportedly widening with implications for the drug firms. </p>